For research use only. Not for human or animal consumption.
What it is
Selank is a synthetic heptapeptide — seven amino acids in a defined order: Thr-Lys-Pro-Arg-Pro-Gly-Pro. The first four residues are tuftsin, a tetrapeptide that occurs naturally; the final three, Pro-Gly-Pro, are a synthetic extension tuftsin does not carry. Three of the seven residues are proline.
The plain facts a genuine vial should match:
- Chemical name: Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
- CAS number: 129954-34-3
- Molecular formula: C33H57N11O9
- Average molecular weight: 751.90
- Monoisotopic mass: 751.434 (PubChem CID 11765600)
- Form: lyophilised (freeze-dried) powder
- Storage: −20°C, desiccated and protected from light
Two structural details decide how the compound can be measured at all. The termini are unmodified: Selank carries a free C-terminal carboxylic acid and a free N-terminus, neither acetylated nor amidated. And the sequence contains no tryptophan, no tyrosine and no phenylalanine — so no aromatic chromophore — and no sulfur-containing residue. It does carry two basic residues, lysine and arginine, which is why it is normally isolated as a salt, most often the acetate.
Those numbers are the molecule’s fingerprint. Purity is determined by HPLC and identity confirmed by mass spectrometry, on a certificate issued per lot by a named third-party laboratory. If the paperwork does not match the fingerprint, the vial is not what the label claims.
What researchers are studying
The published Selank work is preclinical — rats, mice and immortalised cell lines, not people. What follows is what has been measured, and in which model.
- Researchers measured transcript levels across a panel of 84 genes involved in neurotransmission — GABA receptor subunits, transporters, ion channels, dopamine and serotonin receptors — by real-time PCR in the frontal cortex of male Wistar rats, 1 and 3 hours after exposure at the amounts described in the paper. [1]
- A second group assayed the same 84-gene panel by qPCR in human neuroblastoma IMR-32 cell culture, alone and combined with GABA or olanzapine. The authors reported no change in the transcripts examined under the peptide alone — a negative finding, and worth reading as one. [2]
- Radioligand-receptor binding analysis on isolated brain-cell plasma membrane preparations, in which the authors measured how tritiated GABA binding shifted in the presence of the heptapeptide. HPLC was used in that work to establish the purity of the peptide reagent before assay. [3]
- A time course of C3, Casp1, Il2rg and Xcr1 transcript levels measured in mouse spleen by real-time PCR, run alongside the Gly-Pro dipeptide fragment so the fragment’s contribution could be separated from that of the intact heptapeptide. [4]
- Object-recognition test readouts recorded in outbred rats maintained on long-term ethanol exposure as their only fluid source, on the schedule described in the paper, paired with ex vivo measurement of brain-derived neurotrophic factor content in dissected hippocampus and frontal cortex. [5]
- Placement of the compound within the broader class of agents acting at gamma-aminobutyric acid receptors, in a pharmacology review written independently of the originating laboratories. [6]
What the literature does not cover
The Selank record is thin and unusually concentrated. A PubMed search for the term returns roughly 135 indexed records, and a large share of the substantive work originates from two Russian institutions — the Institute of Molecular Genetics of the Russian Academy of Sciences and the V. V. Zakusov Research Institute of Pharmacology — frequently with overlapping author lists. Independent replication outside those institutes is scarce. Almost everything readable in English is preclinical; clinical material sits largely in Russian-language psychiatry journals at small sample sizes, without indexed English full text. The 2021 review in The Journal of Clinical Pharmacology [6], authored at the University of Connecticut with no connection to the originating laboratories, characterises selank as poorly studied.
Selank holds no FDA approval for any indication. Findings in rats, in mice and in immortalised cell lines do not transfer to people, and nothing in this literature establishes any outcome in a human being.
How to verify a vial of Selank before you pay
Five checks, all readable off a certificate of analysis in about a minute.
1. Read the mass, not the vial text. Selank and Semax share the same C-terminal Pro-Gly-Pro extension — which is where the resemblance ends. Selank is tuftsin-PGP: C33H57N11O9, 751.90. Semax is ACTH(4-7)-PGP: C37H51N9O10S, 813.93. Semax contains methionine and phenylalanine; Selank contains no sulfur and no aromatic residue at all. Roughly 62 Da separates them, and a mass-spectrometry trace resolves that in one glance — but only for the buyer who opens the certificate.
2. Watch the charge state. At 751.9 with two basic sites, the doubly protonated ion falls near m/z 376.7 — a certificate reporting only that value can be misread as a compound of about half the true mass. The singly protonated ion sits at 752.4, the neutral monoisotopic mass at 751.4. That arithmetic has produced identity disputes on other short peptides.
3. Check the detection wavelength. With no tryptophan, tyrosine or phenylalanine, Selank does not absorb meaningfully at 280 nm; purity has to be run near 214 nm, on the peptide bond itself. A 214 nm trace also responds to non-peptide species, which makes the wavelength printed on the certificate load-bearing information — and it is frequently absent from what a vendor shows.
4. Name the laboratory, and match the lot. The certificate should name an outside laboratory, not the seller’s own bench, and a report for a different batch says nothing about the vial in hand. Clarion publishes a public lot ledger where the lot stamped on the vial resolves to that lot’s own signed third-party certificate; for the current Selank lot, that certificate is issued by Freedom Diagnostics Testing. The release specification is >99% by HPLC main peak with MS-confirmed identity. 5. Separate area-percent from net peptide content. An HPLC purity figure describes the chromatogram, not what share of the powder is peptide. Selank is isolated as a salt, usually the acetate, and a lyophilised powder retains counterion and residual water — so a vial labelled 10 mg describes gross fill. Amino-acid analysis or nitrogen determination answers that question, and is rarely supplied. Synthesis failure sequences — loss of the terminal proline, loss of the glycine — elute close to the parent, so one purity number does not by itself show the related-substance profile was resolved.
Common questions
What is Selank, in one line? A synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro (CAS 129954-34-3, C33H57N11O9, 751.90), supplied as a lyophilised powder for research use only.
How is Selank different from Semax? Different parent sequence, different mass. Selank is tuftsin plus Pro-Gly-Pro at 751.90; Semax is ACTH(4-7) plus Pro-Gly-Pro at 813.93, and carries sulfur and an aromatic residue that Selank does not.
Is “N-acetyl Selank amidate” the same molecule? No, and it is harder to pin down. Selank resolves cleanly to PubChem CID 11765600 under CAS 129954-34-3; a PubChem lookup for the acetylated variant resolves separately to PubChem CID 133082488 (N-Acetyl selank, C35H59N11O10, MW 793.9), so a reference structure does exist to check a vendor’s claim against. Vendor listings are also internally inconsistent: the formula commonly quoted, C35H59N11O10 at about 793.9, carries the same eleven nitrogens as Selank — which describes N-terminal acetylation alone, with no added amide nitrogen for the C-terminal amidation the name asserts. Anyone wanting unmodified Selank should confirm the observed mass sits at 751.4 monoisotopic, not roughly 42 Da higher.
How should it be stored? At −20°C, desiccated and protected from light.
Is this a medicine? No. It is a research-use-only material, not for human or animal consumption, and it holds no FDA approval for any indication.
References
Titles are omitted below where the published wording carries claim-style phrasing that does not belong in research-use-only copy; each entry is identified by author, journal, year, PMID and DOI, with its subject described in neutral terms.
- Volkova A, et al. Frontiers in Pharmacology. 2016;7:31. PMID: 26924987. DOI: 10.3389/fphar.2016.00031. (Rat model; real-time PCR of an 84-gene neurotransmission panel in frontal cortex.)
- Filatova E, et al. Frontiers in Pharmacology. 2017;8:89. PMID: 28293190. DOI: 10.3389/fphar.2017.00089. (Human neuroblastoma IMR-32 cell culture; qPCR of the same 84-gene panel, alone and with GABA or olanzapine.)
- Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N. Protein and Peptide Letters. 2018;25(10):914–923. PMID: 30255741. DOI: 10.2174/0929866525666180925144642. (In vitro radioligand-binding measurements on brain-cell plasma membrane preparations.)
- Kolomin T, et al. Molecular Immunology. 2014;58(1):50–55. PMID: 24291245. DOI: 10.1016/j.molimm.2013.11.002. (Mouse model; real-time PCR time course of four immune-signalling transcripts in spleen.)
- Kolik LG, et al. Bulletin of Experimental Biology and Medicine. 2019;167(5):641–644. PMID: 31625062. DOI: 10.1007/s10517-019-04588-9. (Rat model; object-recognition readouts under long-term ethanol exposure, with ex vivo BDNF measurement in hippocampus and prefrontal cortex.)
- Doyno CR, White CM. The Journal of Clinical Pharmacology. 2021;61(Suppl 2):S114–S128. PMID: 34396551. DOI: 10.1002/jcph.1922. (Review of agents acting at gamma-aminobutyric acid receptors, written independently of the originating laboratories.)
Chemistry cross-checked against PubChem CID 11765600 (CAS 129954-34-3), retrieved 2026-08-19. Every reference above was confirmed against the live PubMed record before publication.
Related: How to verify a peptide certificate of analysis.
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), CAS 129954-34-3, C33H57N11O9, 751.90 — HPLC purity and MS-confirmed identity on a signed third-party certificate, matched to the lot stamped on the vial. For research use only. Not for human or animal consumption. Not a drug.
